4
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patent Update: Central & Peripheral Nervous System: Recent patent activity relating to serotonin pharmacology

Pages 1233-1241 | Published online: 03 Mar 2008

References to Primary Literature

  • SHUISKE GM: Exp. Opin. Therapeutic Patents (1994) 4: 335–341.
  • DAVIES HML, SAIKALI E, HUBY NJS, GILLIATT VJ, MATASI J, SEXTON T, CHILDERS SR: J. Med. Chem. (1994) 37: 1262–1268.
  • RUPP A, KOVAR KA, BEUERLE G, RUF C, FOLICERS G:
  • •Pharm. Acta He/v. (1994) 68: 235–244. A model for amphetamine-like SSRIs
  • GOADSBY PJ, ZAGAMI AS, DONNAN GA, SYMINGTON G, ATHONY M, BLADIN PF, LANCE JW: Lancet (1991) 338: 782–783
  • STREET LJ, BAKER R, CASTRO JL, CHAMBERS MS, GUIB-LIN AR, HOBBS SC, MATASSA VG, REEVE AJ, BEER MS, MIDDLEMISS DN: J. Med. Chem. (1993) 36: 1529–1538.
  • BEER MS, STANTON JA, BEVAN Y, HEALD A, REEVE, AJ, STREET LJ, MATASSA VG, HARGREAVES RJ, MIDDLEMISS DN: Br. J. Pharmacol. (1993) 110: 1196–1200.
  • GLENNON RA, Neurasci. Biobehav. Rev. (1990) 14: 35–47.
  • LIN CH, HAADSMA-SVENSSON SR, PHILLIPS G, MCCALL RB, PIERCEY, MF, SMITH MW, SVENSSON K, CARLSSON A, CHIDESTER CG, VON VOIGTLANDER PF: J. Med. Chem. (1993) 36: 2208–2218.
  • MILLAN MJ, CANTON H, GOBERT A, LEJEUNE F, RIVE'T JM, BERVOETS K, BROCCO M, WIDDOWSON P, MENNINI T, AUDINOT V: J. Pharmacol. Exp. flier. (1994) 268: 337–352.
  • MILLAN MJ, RIVET JM, CANTON H, LEJEUNE F, GOBERT A, WIDDOWSON P, BERVOETS K, BROCCO M, PEGLION JL: Eur. J. Pharmacol. (1993) 230: 99–102.
  • ZHUANG Z-P, KUNG M-P, KUNG HF: J. Med. Chem. (1994) 37: 1406–1407.A good review of 5-HT1A pharmacology
  • SIMIAND J, KEANE PE, BARNOUIN MC, KEANE M, SOUBR1EP, LE FUR G: Fundam.Pharmacol. (1993) 7: 413–427.
  • BACHY A, STEINBERG R, SANTUCCI V, FOURNIER M, LANDI M, HAMON M, MANARA L, KEANE PE, SOUBRIE P, LE FUR G: Fundam. Clin. Pharmacol. (1993) 7: 487–497.
  • SONESSON C, BOIJE M, SVENSSON K, EKMAN A, CARLSSON A, ROMERO AG, MARTIN IJ, DUNCAN JN, KING LJ, IXTIKSTROM H: J. Med. Chem. (1993) 36: 3409–3416.
  • LIN CH, HAADSMA-SVENSSON SR, LAHTI RA, MCCALL RB, PIERCE, MF, SCHREUR PJ, VON VOIGTLANDER PF, SMITH MW, CHIDESTER CG: J. Med. Chem. (1993) 36: 1053–1068.
  • LIN CH, HAADSMA-SVENSSON SR, PHILLIPS G, MCCALL RB, PIERCEY MF, SMITH MW, SVENSSON K, CARLSSON A, CHIDESTER CG, VON VOIGTLANDER PF: J. Med. Chem. (1993) 36: 2208–2218.
  • LIN CH, HAADSMA-SVENSSON SR, PHILLIPS G, LAHTI RA,MCCALL RB, PIERCEY MF, SCHREUR PJ, VON VOIGTLAN-DER PF, SMITH MW, CHIDESTER CG: J. Med. Chem. (1993) 36: 1069–1083.
  • STJERNLOF P, GULLME M, ELEBRING T, ANDERSSON B,WIKSTROM H, LAGERQUIST S, SVENSSON K, EKMAN A, CARLSSON A, SUNDELL 5:1 Med. Chem. (1993) 36: 2059–2065.
  • ROMERO AG, LEIBY JA, MCCALL RB, PIERCEY MF, SMITH MW, HAN F: J. Med. Chem. (1993) 36: 2066–2074.
  • YU H, LIU Y, HACKSELL U, LEWANDER T: Eur.J. Pharmacol. (1993) 231: 69–76.
  • HACKSELL U, LIU Y, YU H, VALLGARDA J, HOOK BB,JOHANSSON AM, LEWANDER T: Drug Des. Discov. (1993) 9: 287–297. Predictive model for aminotetralin 5-HT1A agonists.
  • HERNDON JL, ISMAIEL A, INGHER SP, TEITLER M, GLEN NON RA: 1 Med. Chem. (1992) 35: 4903–4910. Structure-affinity relationships of some ketanserin analogues.
  • MOKROSZ JL, CHARAKCHLEVA-MINOL S, PALUCHOWSKA MU, CEGLA MT: Pol. 1 Pharmacol. Pharm. (1992) 44: 595–607. Structure-activity relationships of some 3-chlorophenylpiperidines.
  • BOGESO KP, ARNT J, HYFTEL J, PEDERSEN H:J. Med. Chem. (1993) 36: 2761–2770.
  • PERREGAARD J, ANDERSEN K, HYTTEL J, SANCHEZ C: J.Med. Chem. (1992) 35: 4813–4822.
  • ANDERSEN K, PERREGAARD J, ARNT J, NIELSEN JB, BEGTRUP M: J. Med. Chem. (1992) 35: 4823–4831.
  • ISMAEL AM, DE LOS ANGELES J, TEITLER M, INGHER S,GLENNON RAJ Med. Chem. (1993) 36: 2519–2525.
  • GROVER GJ, SARGENT CA, DZWONCZYK S, NORMANDIN D.E, ANTONACCIO MI: J. Cardiovasc. Pharmacol. (1993) 22: 664–672.
  • BRAMBILLA A, GHIORZI A, PITSIKAS N, BORSINi F: J. Pbarm. Pharmacol. (1993) 45: 841–843.
  • PITSIKAS N, BRAMBILLA A, BORSINI F: Neurobiol. Ageing (1993) 14: 561–564.
  • PITSIKAS N, BRAMBILLA A, BORSINI F: Pharmacol. Bio-chem. Behav. (1994) 47: 95–99.
  • BACHY A, HEAULME M, GIUDICE A, MICHAUD JC, LE-FEVRE IA, SOUILHAC J, MANARA L, EMERIT MB, GOZLAN H, HAMON M: Eur. J. Pharmacol. (1993) 237: 299–309.
  • COSTALL B, NAYLOR RJ: int. Clin. Psychopbarmacol. (1993)8 (suppl 2)11–18. A good review of 5-HT4 receptor pharmacology.
  • KING Fl), HADLEY MS, JOINER KT, MARTIN RT, SANGER aGJ, SMITH DM, SMITH GE, SMITH P, TURNER DH, WAITSEA: j Med. Chem. (1993) 36: 683–689. Structure activity relationships of some 5-HT.4 ligands.
  • GASTER LM, JENNINGS AJ, JOINER GF, KING FD, MULHOL-LAND KR, RAHMAN SK, STARR S, WYMAN PA, WARDLE KR, ELLIS ES: J. Med. Chem. (1993) 36:4121–4123.
  • MONGE A, PENA MDC, PALOP JA, CALDER°, JM, ROCA J, GARCIA E, ROMERA G, RIO JD LASHERAS B: J. Med. Chem. (1994) 37: 1320–1326.
  • SHEN Y, MONSMA JRFJ, METCALF MA, JOSE PA, HAMBLIN MW, SIBLEY DR: J. Biol. Chem. (1993) 268: 18200–18204.
  • MONSMA JR FJ, SHEN Y, WARD RP, HANBLIN MW, SIBLEY DR: Mot. Pharmacol. (1993) 43: 230–237.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.